Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.684)

61

Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension

enthalten in: Epilepsia open | 2024

von Nishida, T. | Lee, S. | Inoue, Y. | +5

62

Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density : A Secondary Analysis of a Phase 3 Randomized Controlled Trial

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Roy, S. | Malone, S. | Sun, Y. | +8

63

FDA Approval Summary : Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Woods, A. | Norsworthy, K. | Wang, X. | +9

64

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

65

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

66

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype : A Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Lorusso, D. | Raspagliesi, F. | Ronzulli, D. | +20

67

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy : A Phase 3 Randomized Clinical Trial in China

enthalten in: Diabetes | 2024

von Guo, L. | Pan, Q. | Cheng, Z. | +10

68

Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases : A Randomized, Double-Blind, Phase 3 Equivalence Trial

enthalten in: JAMA oncology | 2024

von Zhang, S. | Yin, Y. | Xiong, H. | +36

69

Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer : Final Results of the POUT Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Birtle, A. | Jones, R. | Chester, J. | +14

70

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients : 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Malagola, M. | Iurlo, A. | Bucelli, C. | +27